Smith A L, Barthold S W, de Souza M S, Bottomly K
Section of Comparative Medicine, Yale University School of Medicine, New Haven, Connecticut.
Arch Virol. 1991;121(1-4):89-100. doi: 10.1007/BF01316746.
Infection of BALB/c mice with mouse hepatitis virus, strain JHM (MHV-JHM), at any of several intervals relative to ovalbumin (OVA) administration resulted in elevated OVA-specific IgG 2 a titers. Since gamma interferon (IFN) has been implicated as an up-regulator of IgG 2 a production, attempts were made to determine whether levels of this cytokine were modified in sera of infected mice. Serum IFN-gamma was not detected, but treatment of MHV-JHM-infected mice with monoclonal anti-IFN-gamma antibody resulted in high mortality with decreased survival times, enhanced virus titers in liver and spleen, and more severe virus-associated pathology, compared to mock-treated, infected mice. Immunotherapy with recombinant IFN-gamma ameliorated disease as reflected by mortality rates and virus titers in target organs.
在相对于卵清蛋白(OVA)给药的几个不同时间间隔的任何一个时间,用小鼠肝炎病毒JHM株(MHV-JHM)感染BALB/c小鼠,都会导致OVA特异性IgG 2a滴度升高。由于γ干扰素(IFN)被认为是IgG 2a产生的上调因子,因此尝试确定感染小鼠血清中这种细胞因子的水平是否发生改变。未检测到血清IFN-γ,但与模拟处理的感染小鼠相比,用单克隆抗IFN-γ抗体治疗MHV-JHM感染的小鼠导致高死亡率、存活时间缩短、肝脏和脾脏中的病毒滴度升高以及更严重的病毒相关病理学变化。用重组IFN-γ进行免疫治疗改善了疾病,这体现在死亡率和靶器官中的病毒滴度上。